Next Article in Journal
Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines
Previous Article in Journal
Hepatitis B At-Birth Dose Vaccine: An Urgent Call for Implementation in Ghana
Article Menu

Export Article

Open AccessArticle

Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin

1
Department of Microbiology and Immunology, Wake Forest School of Medicine, Winston Salem, NC 27101, USA
2
Department of Biochemistry, Wake Forest School of Medicine, Winston Salem, NC 27101, USA
3
Department of Pathology, Section of Comparative Medicine, Wake Forest School of Medicine, Winston Salem, NC 27101, USA
*
Author to whom correspondence should be addressed.
Vaccines 2018, 6(1), 16; https://doi.org/10.3390/vaccines6010016
Received: 26 February 2018 / Revised: 16 March 2018 / Accepted: 18 March 2018 / Published: 19 March 2018
  |  
PDF [1449 KB, uploaded 3 May 2018]
  |  

Abstract

Recombinant vesicular stomatitis virus (VSV) is a promising platform for vaccine development. M51R VSV, an attenuated, M protein mutant strain, is an effective inducer of Type I interferon and dendritic cell (DC) maturation, which are desirable properties to exploit for vaccine design. We have previously evaluated M51R VSV (M51R) and M51R VSV that produces flagellin (M51R-F) as vaccine vectors using murine models, and found that flagellin enhanced DC activation and VSV-specific antibody production after low-dose vaccination. In this report, the immunogenicity of M51R vectors and the adjuvant effect of virus-produced flagellin were evaluated in nonhuman primates following high-dose (108 pfu) and low-dose (105 pfu) vaccination. A single intramuscular vaccination of African green monkeys with M51R or M51R-F induced VSV-specific, dose-dependent humoral immune responses. Flagellin induced a significant increase in antibody production (IgM, IgG and neutralizing antibody) at the low vaccination dose. A VSV-specific cellular response was detected at 6 weeks post-vaccination, but was neither dose-dependent nor enhanced by flagellin; similar numbers of VSV-specific, IFNγ-producing cells were detected in lymph node and spleen of all animals. These results indicate that virus-directed, intracellular flagellin production may improve VSV-based vaccines encoding heterologous antigens by lowering the dose required to achieve humoral immunity. View Full-Text
Keywords: vesicular stomatitis virus; vaccine; vector; flagellin; nonhuman primate; African green monkey vesicular stomatitis virus; vaccine; vector; flagellin; nonhuman primate; African green monkey
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Westcott, M.M.; Smedberg, J.; Jorgensen, M.J.; Puckett, S.; Lyles, D.S. Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin. Vaccines 2018, 6, 16.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top